Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Translational Neuroscience | Lifetime achievement Award

Assist. Prof. Dr. Chun-An Cheng | Tri-Service General Hospital | Taiwan

Assistant Professor Dr. Chun-An Cheng is a distinguished researcher affiliated with the Tri-Service General Hospital, Taiwan, known for his significant contributions to medical and clinical research. He has authored 73 scholarly documents, which have collectively garnered 658 citations across 620 publications, reflecting the wide impact and recognition of his scientific work. With an h-index of 14, Dr. Cheng has demonstrated consistent research productivity and influence within his field. His research encompasses multidisciplinary areas in clinical medicine, focusing on advancing diagnostic methodologies, therapeutic innovations, and patient-centered healthcare strategies. Through his collaborations and publications, Dr. Cheng has contributed to improving the understanding of complex medical conditions and enhancing evidence-based clinical practices. His dedication to translational research bridges the gap between laboratory findings and clinical applications, reinforcing his role as a key figure in the Taiwanese medical research community. Dr. Cheng continues to drive impactful studies that promote innovation, patient safety, and improved health outcomes, positioning him as a leading voice in contemporary clinical science.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • (2025). Effects of exposure to air pollution and cold weather on acute myocardial infarction mortality. Atmosphere.

  • (2025). The risk of ischemic stroke in patients with chronic obstructive pulmonary disease and atrial fibrillation. Life.

  •  (2024). Increased risk of psychiatric disorder in patients with hearing loss: A nationwide population-based cohort study. Journal of Translational Medicine.

  • (2024). Diabetes mellitus and gynecological and inflammation disorders increased the risk of pregnancy loss in a population study. Life.

  • (2024). The influence of fine particulate matter and cold weather on emergency room interventions for childhood asthma. Life.

  • (2024). Impact of foodborne disease in Taiwan during the COVID-19 pandemic. Medicina (Lithuania).

  • (2024). Analyzing COVID-19 and air pollution effects on pediatric asthma emergency room visits in Taiwan. Toxics.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.

Victoria Carter | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Victoria Carter | Emerging Areas in Neuroscience | Best Researcher Award

Dr. Victoria Carter | VCA West Coast Vet Hospital | United States

Victoria Carter is a highly skilled small-animal internal-medicine clinician and researcher whose diverse training and leadership reflect her commitment to veterinary excellence. After earning a BSc (Hons) in Biological Science from the University of Guelph in Canada, followed by a DVMS (Bachelor of Veterinary Medicine & Surgery) from the Royal (Dick) School of Veterinary Studies in Edinburgh (where she received multiple awards including the CEVA Dermatology Prize and the Outstanding Student Leadership Award), she completed internships, a residency in Small Animal Internal Medicine at the University of Pennsylvania – Matthew J. Ryan Veterinary Hospital, and now serves as one of the lead internal medicine clinicians at the VCA West Coast Specialty & Emergency Animal Hospital in Fountain Valley, CA. Her clinical repertoire includes advanced endoscopic procedures (gastroduodenoscopy, ileocolonoscopy, bronchoscopy, rhinoscopy, cystoscopy/vaginoscopy and tracheoscopy) and she is experienced in high-volume inpatient and outpatient settings, collaborating across hospital services to tailor diagnostics and care plans for complex cases. Her research interests include immune-mediated diseases, such as primary immune-mediated neutropenia in the context of an earlier-diagnosed Evans syndrome in dogs (Carter & Silvestrini, Vet Rec Case Rep) and a retrospective international study on hypercobalaminaemic cats in progress under mentor Paolo Silvestrini MSc, PhD, DECVIM(CA). She has authored [DOCUMENTS-COUNT] publications, amassed [CITATIONS-COUNT] citations, and holds an h-index of [H-INDEX]. A native Canadian, fluent in English and French, she brings strong leadership, communication and interpersonal skills — especially in high-pressure environments — and fosters a positive, collaborative veterinary team culture while building excellent relationships with clients and patients.

Profile: Orcid

Featured Publication

Carter, V., & Silvestrini, P. (2025, September 24). Primary immune‐mediated neutropenia as part of a relapse of previously diagnosed Evans syndrome in a dog. Veterinary Record Case Reports.

Yue Ding | Cognitive Neuroscience | Best Researcher Award

Dr. Yue Ding | Cognitive Neuroscience | Best Researcher Award

Dr. Yue Ding | Shanghai Mental Health Center | China

Dr. Yue Ding is a distinguished neuroscientist and biomedical engineer whose research focuses on the neural mechanisms of music and rhythm-based interventions for affective and anxiety disorders, particularly in children and adolescents. With a Ph.D. in Neuroscience from Tsinghua University and a B.S. in Biomedical Engineering from Dalian University of Technology, Dr. Ding has extensive experience in both academic and industry settings, including leadership roles at Shanghai Mental Health Center, AI Institute at iFlytek, and Nielsen Consumer LLC, as well as a visiting scholar position at Johns Hopkins University. Dr. Ding’s research integrates neuroscience, artificial intelligence, and virtual reality to develop personalized interventions, including closed-loop music therapies, rhythm interactive training, and controllable music generation models, supported by numerous national and municipal grants. His work also explores neural oscillations in depression and anxiety, taste perception, and language impairments in Alzheimer’s patients. He is actively involved in professional organizations, including the Art Psychotherapy Committee, Music Psychology Committee, and editorial boards of prominent journals such as Scientific Reports and Frontiers in Psychiatry. With 17 published documents, Dr. Ding has garnered 228 citations and holds an h-index of 8, reflecting his influential contributions to the fields of neuroscience, neuroengineering, and mental health research.

Profiles: Scopus | Google Scholar | Linked In

Featured Publications

Ding, Y., Hu, X., Li, J., Ye, J., Wang, F., & Zhang, D. (2018). What makes a champion: The behavioral and neural correlates of expertise in multiplayer online battle arena games. International Journal of Human–Computer Interaction, 34(8), 682–694.

Ding, Y., Hu, X., Xia, Z., Liu, Y. J., & Zhang, D. (2021). Inter-brain EEG feature extraction and analysis for continuous implicit emotion tagging during video watching. IEEE Transactions on Affective Computing, 12(1), 92–102.

Ding, Y., Zhang, Y., Zhou, W., Ling, Z., Huang, J., Hong, B., & Wang, X. (2019). Neural correlates of music listening and recall in the human brain. Journal of Neuroscience, 39(41), 8112–8123.

Ding, Y., Chu, Y., Liu, M., Ling, Z., Wang, S., Li, X., & Li, Y. (2022). Fully automated discrimination of Alzheimer’s disease using resting-state electroencephalography signals. Quantitative Imaging in Medicine and Surgery, 12(2), 1063–1077.

Ding, Y., Gray, K., Forrence, A., Wang, X., & Huang, J. (2018). A behavioral study on tonal working memory in musicians and non-musicians. PLOS ONE, 13(8), e0201765.

Zhang, Y., Ding, Y., Huang, J., Zhou, W., Ling, Z., Hong, B., & Wang, X. (2021). Hierarchical cortical networks of “voice patches” for processing voices in human brain. Proceedings of the National Academy of Sciences of the United States of America, 118(44), e2103518118.

Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | Neurochemistry | Best Researcher Award

Dr. Efstratios Stylianos Pyrgelis | National and Kapodistrian University of Athens | Greece

Dr. Efstratios-Stylianos Pyrgelis is a distinguished Neurologist and Ph.D. scholar affiliated with the National and Kapodistrian University of Athens. His extensive research contributions span neurochemistry, neuroimaging, and normal pressure hydrocephalus, reflecting a deep commitment to advancing clinical neuroscience. With over 40 published articles in SCI- and Scopus-indexed journals and authorship of 4 international medical books, Dr. Pyrgelis has established a strong academic footprint. His scholarly influence is demonstrated by a total of 510 citations, an h-index of 11, and an i10-index of 12, as recorded on Google Scholar. As a Review Editor for Frontiers in Neurology and Guest Editor for Diagnostics, he plays a pivotal role in shaping contemporary neurological research. He collaborates with the CNS Alliance Research Group and maintains professional memberships with the Greek Neurologic Society and the Medical Association of Chios. Beyond academia, he has contributed to consultancy projects linking research with clinical applications. Through his innovative work and international collaborations, Dr. Pyrgelis continues to contribute significantly to the understanding and treatment of neurological disorders, reinforcing his reputation as one of Greece’s leading researchers in the field of neuroscience.

Profiles: Orcid | Research Gate

Featured Publications

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Stefanis, L., & Kapaki, E. (2024). In vivo prevalence of beta-amyloid pathology and Alzheimer’s disease co-pathology in idiopathic normal-pressure hydrocephalus—Association with neuropsychological features. Biomedicines, 12(8), 1898.

Pyrgelis, E.-S., Paraskevas, G. P., Constantinides, V. C., Boufidou, F., Papaioannou, M., Stefanis, L., & Kapaki, E. (2023). Alzheimer’s disease CSF biomarkers as possible indicators of tap-test response in idiopathic normal pressure hydrocephalus. Brain Sciences, 13(11), 1593.

Angelopoulou, E., Pyrgelis, E.-S., Ahire, C., Suman, P., Mishra, A., & Piperi, C. (2023). Functional implications of protein arginine methyltransferases (PRMTs) in neurodegenerative diseases. Biology, 12(9), 1257.

Pyrgelis, E.-S., Velonakis, G., Papageorgiou, S. G., Stefanis, L., Kapaki, E., & Constantinides, V. C. (2023). Imaging markers for normal pressure hydrocephalus: An overview. Biomedicines, 11(5), 1265.

Constantinides, V. C., Paraskevas, G. P., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Stefanis, L., & Kapaki, E. (2023). CSF Aβ42 and Aβ42/Aβ40 ratio in Alzheimer’s disease and frontotemporal dementias. Diagnostics, 13(4), 783.

Constantinides, V. C., Boufidou, F., Bourbouli, M., Pyrgelis, E.-S., Ghika, A., Koros, C., Liakakis, G., Papageorgiou, S., Stefanis, L., Paraskevas, G. P., et al. (2023). Application of the AT(N) and other CSF classification systems in behavioral variant frontotemporal dementia. Diagnostics, 13(3), 332.

Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022). Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: An update on preclinical and clinical evidence. Molecules, 27(23), 8448.

Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri | Foundations of Neuroscience | Best Researcher Award

Dr. Eleni Tsakiri |  National and Kapodistrian University of Athens Medical School | Greece

Dr. Eleni Tsakiri is a distinguished Molecular Biologist whose research centers on the molecular mechanisms of aging, proteostasis, and neurodegeneration. She earned her Ph.D. in Biology from the National and Kapodistrian University of Athens (NKUA) with a thesis on proteome homeostasis and its alterations during aging, following her M.Sc. in Cell Biology and Biophysics and a B.Sc. in Molecular Biology and Genetics. Dr. Tsakiri has held multiple postdoctoral positions at leading Greek institutions, including the Medical School of NKUA and the Biomedical Research Center “Alexander Fleming,” where she contributed to projects on proteasome regulation, Tau aggregation, and ribosome-mediated cell competition. Currently, she serves as a Postdoctoral Researcher at the Laboratory of Physiology, NKUA, focusing on neurodegeneration and aging under an ERC-funded project. Her research is supported by competitive grants such as the Hellenic Foundation for Research and Innovation (HFRI). She has supervised undergraduate, master’s, and doctoral students and actively collaborates with prominent researchers in Greece and abroad. Dr. Tsakiri’s contributions are reflected in her 24 published documents, 730 citations, and an h-index of 15, highlighting her impact in molecular biology and aging research.

Profiles: Scopus | Google Scholar | Research Gate | LInked In

Featured Publications

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Terpos, E., Dimopoulos, M. A., & others. (2013). Proteasome dysfunction in Drosophila signals to an Nrf2‐dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell, 12(5), 802–813.

  • Tsakiri, E. N., Sykiotis, G. P., Papassideri, I. S., Gorgoulis, V. G., Bohmann, D., & others. (2013). Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress. The FASEB Journal, 27(6), 2407–2419.

  • Tsakiri, E. N., & Trougakos, I. P. (2015). The amazing ubiquitin-proteasome system: Structural components and implication in aging. International Review of Cell and Molecular Biology, 314, 171–237.

  • Tsakiri, E. N., Iliaki, K. K., Höhn, A., Grimm, S., Papassideri, I. S., & Grune, T. (2013). Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster. Free Radical Biology and Medicine, 65, 1155–1163.

  • Tsakiri, E. N., Gumeni, S., Iliaki, K. K., Benaki, D., Vougas, K., Sykiotis, G. P., et al. (2019). Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation. Aging Cell, 18(1), e12845.

Sofia Gandolfi | Developmental Neuroscience | Best Researcher Award

Ms. Sofia Gandolfi | Developmental Neuroscience | Best Researcher Award

Ms. Sofia Gandolfi | Fondazione IRCCS Istituto Neurologico Carlo Besta | Italy

Ms. Sofia Gandolfi is an Italian Speech and Language Therapist specializing in the assessment and management of swallowing disorders, particularly in children with neurogenic and neuromuscular conditions such as Spinal Muscular Atrophy. She has gained extensive clinical experience at the Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan, where she performs swallowing screenings, clinical evaluations, and develops individualized rehabilitation plans involving therapy, compensatory strategies, and dietary recommendations in collaboration with multidisciplinary teams that include neurologists, ENT specialists, gastroenterologists, dietitians, and physiotherapists. Her work emphasizes evidence-based interventions to enhance swallowing safety, efficiency, and quality of life for patients. Sofia also has experience in assessing and treating children and adults with neurodevelopmental and neurodegenerative disorders, both in outpatient settings and home-based care. Beyond clinical practice, she has contributed to research on swallowing physiology, intervention efficacy, and quality improvement initiatives in dysphagia services. She holds a Master of Science in Clinical Speech and Language Studies with a specialization in Dysphagia from Trinity College Dublin. Her academic contributions are reflected in 1 published document, 1 citation, and an h-index of 1, demonstrating her emerging engagement in research and her commitment to advancing clinical practices in speech and swallowing therapy.

Profiles: Google Scholar | Orcid | Research Gate | Linked In

Featured Publications

Mozzanica, F., Pizzorni, N., Gitto, M., Dosi, C., Mandelli, A., Gandolfi, S., & others. (2024). Fiberoptic endoscopic evaluation of swallowing (FEES) in children with spinal muscular atrophy type 1: Feasibility, swallowing safety and efficacy, and dysphagia phenotype. European Archives of Oto-Rhino-Laryngology, 281(12), 6523–6532.

Gandolfi, S., Dosi, C., Parravicini, S., Arnoldi, M. T., Zanin, R., Biagi, S., Rinaldi, L., & others. (2025). Exploring the trajectory of swallowing within psychomotor development in spinal muscular atrophy: Moving toward integrated care. Audiology Research.

Masson, R., Dosi, C., Parravicini, S., Scopelliti, M., Arnoldi, M., Zanin, R., & others. (2025). 519P The challenge of swallowing assessment in SMA1: Dysphagia clinical features and available assessment tools. Neuromuscular Disorders, 53, 105608.

Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Zhou Yu | Behavioral Neuroscience | Best Researcher Award

Dr. Yu Zhou is a postdoctoral researcher at Army Engineering University, specializing in the intersection of neuroscience, computer vision, and target detection. His research primarily focuses on deceptive visual design for both human and machine perception, exploring how visual stimuli can influence detection, recognition, and cognitive processing. Zhou has conducted pioneering studies on camouflage and optical deception, utilizing EEG-based brain functional network analysis to evaluate target visibility and cognitive responses. His work integrates principles from weapon science, biomedical engineering, and computer science to develop comprehensive models of visual perception and deception. Representative publications include investigations into neural responses to camouflage targets with varying exposure signs, the impact of color differences on brain activation patterns, and feasibility assessments of optical camouflage effects. Through these studies, he contributes to a deeper understanding of how visual designs can manipulate human attention and computer vision systems, providing actionable insights for defense technology applications. Zhou’s research emphasizes rigorous quantitative evaluation methods, leveraging neurophysiological data to inform the design of effective deceptive visual patterns. With an h-index of 2 and multiple citations, his work demonstrates a growing influence in fields spanning neuroscience-informed computer vision, perceptual deception, and applied optical camouflage.

Profiles: Scopus | Reasearch Gate

Featured publication

Author(s). (2024). Neural responses to camouflage targets with different exposure signs based on EEG. Neuropsychologia.

Nasar Ata | Neurology | Best Researcher Award

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.